Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Sihuan Pharmaceutical (0460) Won the Fifth "Listed Enterprises of the Year 2020" Presented by Bloomberg Businessweek/Chinese Edition 2020-12-03 10:36
WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer Value Leadership Award 2020-12-03 08:00
Ecolab donates more than U$200,000 in cleaning and disinfection solutions to help combat COVID-19 in Southeast Asia 2020-12-03 08:00
meldCX unveils SAMi® - digitizing clean-up in public spaces with AI and computer vision 2020-12-03 06:30
IPC Statement On SARS-CoV-2 Vaccines And Psoriasis 2020-12-03 03:56
HemoCue Lab-Accuracy: Soon Counting White Blood Cells in Outer Space. Innovative Technology Onboard SpaceX Falcon 9 Mission CRS-21 - Bound for International Space Station (ISS) 2020-12-03 00:38
Nanoform makes US TV debut in Advancements with Ted Danson (CNBC) 2020-12-02 22:36
WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-stage Innovation and Clinical Research 2020-12-02 22:00
Top Revenue Communities Select Chili Piper as Their Strategic Partner for Meeting Lifecycle Automation 2020-12-02 21:58
Frost & Sullivan Reveals Top Eight Predictions that Will Define Healthcare in 2021 2020-12-02 21:44
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years 2020-12-02 20:00
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation 2020-12-02 19:00
Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application 2020-12-02 18:35
Central IVF Limited's Egg Donation Service Recognized as One of The Most Reputable in Australia 2020-12-02 16:44
PixCell Medical to Enhance NSW Health Pathology's Point-of-Care Testing Service 2020-12-02 14:23
TAT & Locanation launch 'ASQ Paradise' hotel bookings platform 2020-12-02 14:21
Ascentage Pharma Announces Clearances in China and the US for the Phase IIa Study of APG-115 Single Agent or in Combination with APG-2575 for the Treatment of Relapsed or Refractory T-cell Prolymphocytic Leukemia 2020-12-02 08:09
I-Mab Files Shelf Registration Statement for PIPE Investors 2020-12-02 05:23
Bora Pharmaceuticals completes acquisition of former GSK facility 2020-12-01 23:57
Volition Launches Nu.Q™ Vet Cancer Screening Test in the U.S. 2020-12-01 21:45